Low molecular weight heparin use during pregnancy and risk of postpartum hemorrhage: a systematic review and meta-analysis.

Angelo SiricoGabriele SacconeGiuseppe Maria MaruottiElvira GrandoneLaura SarnoVincenzo BerghellaFulvio ZulloPasquale Martinelli

Published in: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (2018)

Women who receive LMWH during pregnancy have a significantly higher risk of developing PPH. Women who receive LMWH during pregnancy have neither significantly higher mean blood loss at delivery nor higher risk of blood transfusion.

Keyphrases

polycystic ovary syndrome
pregnancy outcomes
cervical cancer screening
venous thromboembolism
breast cancer risk
type diabetes
growth factor
insulin resistance